Balance Sheet Data

Outlook Therapeutics, Inc. (OTLK)

$1.57

+0.05 (+3.29%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 3.191.728.0212.5414.4832.2955.6795.99165.51285.37
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 10.953.612.282.392.2038.2866.01113.81196.23338.34
Accounts Payable (%)
Capital Expenditure -0.29-2.78-0.44-4.83-8.32-14.35-24.74-42.67-73.56-126.84
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.